Venderova K et al. |
Differential effects of endocannabinoids on [(3)H]-GABA uptake in the rat globus pallidus. |
2005 |
Exp. Neurol. |
pmid:15899265
|
Kreutz S et al. |
Cannabinoids and neuronal damage: differential effects of THC, AEA and 2-AG on activated microglial cells and degenerating neurons in excitotoxically lesioned rat organotypic hippocampal slice cultures. |
2007 |
Exp. Neurol. |
pmid:17010339
|
Zheng G et al. |
Chronic stress and peripheral pain: Evidence for distinct, region-specific changes in visceral and somatosensory pain regulatory pathways. |
2015 |
Exp. Neurol. |
pmid:26408049
|
Mounsey RB et al. |
Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. |
2015 |
Exp. Neurol. |
pmid:26244281
|
Granchi C et al. |
A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017). |
2017 |
Expert Opin Ther Pat |
pmid:29053063
|
van der Stelt M et al. |
A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease. |
2005 |
FASEB J. |
pmid:15894565
|
DiPatrizio NV et al. |
Endocannabinoid signaling in the gut mediates preference for dietary unsaturated fats. |
2013 |
FASEB J. |
pmid:23463697
|
Bátkai S et al. |
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury. |
2007 |
FASEB J. |
pmid:17327359
|
Siegmund SV et al. |
The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species. |
2007 |
FASEB J. |
pmid:17440119
|
Karwad MA et al. |
The role of CB in intestinal permeability and inflammation. |
2017 |
FASEB J. |
pmid:28404744
|
Maestroni GJ |
The endogenous cannabinoid 2-arachidonoyl glycerol as in vivo chemoattractant for dendritic cells and adjuvant for Th1 response to a soluble protein. |
2004 |
FASEB J. |
pmid:15385435
|
Tam J et al. |
The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling. |
2008 |
FASEB J. |
pmid:17704191
|
Baker D et al. |
Endocannabinoids control spasticity in a multiple sclerosis model. |
2001 |
FASEB J. |
pmid:11156943
|
Alhouayek M et al. |
Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation. |
2011 |
FASEB J. |
pmid:21551239
|
D'Argenio G et al. |
Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation. |
2006 |
FASEB J. |
pmid:16403786
|
Alhouayek M et al. |
N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis. |
2015 |
FASEB J. |
pmid:25384424
|
Di Marzo V et al. |
Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease. |
2000 |
FASEB J. |
pmid:10877836
|
Berdyshev EV et al. |
Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. |
2001 |
FASEB J. |
pmid:11641243
|
Ueda N et al. |
Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways. |
2013 |
FEBS J. |
pmid:23425575
|
Bari M et al. |
In vitro and in vivo models of Huntington's disease show alterations in the endocannabinoid system. |
2013 |
FEBS J. |
pmid:23659592
|